MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (Review)

International Journal of Molecular Medicine

Volumn 34, Issue 4, 2014, Pages 923-933

  Yu, Xin ^a,b   Li, Zheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Atherosclerosis; MicroRNAs; Restenosis; Vascular smooth muscle cells

Indexed keywords

KRUPPEL LIKE FACTOR 4; MICRORNA; MICRORNA 1; MICRORNA 143; MICRORNA 145; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 24; MICRORNA 26A; MICRORNA 31; PLATELET DERIVED GROWTH FACTOR BB; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ATHEROSCLEROSIS; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY; ANIMAL; GENETICS; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; HUMANS; MICRORNAS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 84907470267     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1853     Document Type: Review

References (119)

1. Lusis AJ: Atherosclerosis. Nature 407: 233-241, 2000.
2. Gittenberger-de Groot AC, DeRuiter MC, Bergwerff M and Poelmann RE: Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 19: 1589-1594, 1999. (Pubitemid 29323815)
3. Frid MG, Dempsey EC, Durmowicz AG and Stenmark KR: Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. Arterioscler Thromb Vasc Biol 17: 1203-1209, 1997. (Pubitemid 27329840)
4. Schachter M: Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers. Int J Cardiol 62 (Suppl 2): S85-S90, 1997.
5. Libby P, Sukhova G, Lee RT and Liao JK: Molecular biology of atherosclerosis. Int J Cardiol 62 (Suppl 2): S23-S29, 1997. (Pubitemid 28068793)
6. Schwartz SM: Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 100 (Suppl): S87-S89, 1997.
7. Doran AC, Meller N and McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819, 2008. (Pubitemid 351544093)
8. Huntzinger E and Izaurralde E: Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110, 2011.
9. Cho WC: OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60, 2007.
10. Small EM and Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 469: 336-342, 2011.
11. Song Z and Li G: Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. J Cardiovasc Transl Res 3: 246-250, 2010.
12. Zernecke A: MicroRNAs in the regulation of immune cell functions-implications for atherosclerotic vascular disease. Thromb Haemost 107: 626-633, 2012.
13. Aghabozorg Afjeh SS and Ghaderian SM: The role of microRNAs in cardiovascular disease. Int J Mol Cell Med 2: 50-57, 2013.
14. Robinson HC and Baker AH: How do microRNAs affect vascular smooth muscle cell biology? Curr Opin Lipidol 23: 405-411, 2012.
15. Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004. (Pubitemid 38823766)
16. Stegemann JP, Hong H and Nerem RM: Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol (1985) 98: 2321-2327, 2005.
17. Tang Y, Yang X, Friesel RE, Vary CP and Liaw L: Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells. J Vasc Res 48: 485-494, 2011.
18. Millette E, Rauch BH, Kenagy RD, Daum G and Clowes AW: Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 16: 25-28, 2006. (Pubitemid 43012038)
19. Raines EW: PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15: 237-254, 2004.
20. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
21. Chen J, Yin H, Jiang Y, et al: Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 31: 368-375, 2011.
22. Xie C, Huang H, Sun X, et al: MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 20: 205-210, 2011.
23. Jiang Y, Yin H and Zheng XL: MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J Cell Physiol 225: 506-511, 2010.
24. Suzuki T, Aizawa K, Matsumura T and Nagai R: Vascular implications of the Kruppel-like family of transcription factors. Arterioscler Thromb Vasc Biol 25: 1135-1141, 2005. (Pubitemid 40776599)
25. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH and Owens GK: Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280: 9719-9727, 2005. (Pubitemid 40409670)
26. Yoshida T, Kaestner KH and Owens GK: Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 102: 1548-1557, 2008.
27. King KE, Iyemere VP, Weissberg PL and Shanahan CM: Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morpho genetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 278: 11661-11669, 2003. (Pubitemid 36792729)
28. Wang C, Han M, Zhao XM and Wen JK: Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J Biochem 144: 313-321, 2008.
29. Katakami N, Kaneto H, Hao H, et al: Role of pim-1 in smooth muscle cell proliferation. J Biol Chem 279: 54742-54749, 2004. (Pubitemid 40053219)
30. Wang J, Yan CH, Li Y, et al: MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp Cell Res 319: 1165-1175, 2013.
31. Han Y, Deng J, Guo L, et al: CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Cardiovasc Res 78: 597-604, 2008. (Pubitemid 351769765)
32. Torella D, Iaconetti C, Catalucci D, et al: MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 109: 880-893, 2011.
33. Fichtlscherer S, De Rosa S, Fox H, et al: Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684, 2010.
34. Miano JM: Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35: 577-593, 2003.
35. Madsen CS, Hershey JC, Hautmann MB, White SL and Owens GK: Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem 272: 6332-6340, 1997. (Pubitemid 27118108)
36. Deaton RA, Gan Q and Owens GK: Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol 296: H1027-H1037, 2009.
37. Cordes KR, Sheehy NT, White MP, et al: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009.
38. Raitoharju E, Lyytikäinen LP, Levula M, et al: miR-21, miR-210, miR-34a, and miR-146a/b are upregulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219: 211-217, 2011.
39. Hergenreider E, Heydt S, Tréguer K, et al: Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14: 249-256, 2012.
40. Lovren F, Pan Y, Quan A, et al: MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126 (Suppl 1): S81-S90, 2012.
41. Boettger T, Beetz N, Kostin S, et al: Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119: 2634-2647, 2009.
42. Rangrez AY, Massy ZA, Metzinger-Le Meuth V and Metzinger L: miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4: 197-205, 2011.
43. Chan MC, Hilyard AC, Wu C, et al: Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J 29: 559-573, 2010.
44. Chan MC, Nguyen PH, Davis BN, et al: A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor. Mol Cell Biol 27: 5776-5789, 2007. (Pubitemid 47257833)
45. Leeper NJ, Raiesdana A, Kojima Y, et al: MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 226: 1035-1043, 2011.
46. Liu X, Cheng Y, Zhang S, Lin Y, Yang J and Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487, 2009.
47. Davis BN, Hilyard AC, Nguyen PH, Lagna G and Hata A: Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284: 3728-3738, 2009.
48. Liu X, Cheng Y, Yang J, Xu L and Zhang C: Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 52: 245-255, 2012.
49. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ and Nabel EG: Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82: 396-403, 1998. (Pubitemid 28101197)
50. Stewart MC, Kadlcek RM, Robbins PD, MacLeod JN and Ballock RT: Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differen tiation. J Bone Miner Res 19: 123-132, 2004. (Pubitemid 41295145)
51. Ashman LK: The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol 31: 1037-1051, 1999.
52. Yang G, Pei Y, Cao Q and Wang R: MicroRNA-21 represses human cystathionine gamma-lyase expression by targeting at specificity protein-1 in smooth muscle cells. J Cell Physiol 227: 3192-3200, 2012.
53. Ji R, Cheng Y, Yue J, et al: MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588, 2007. (Pubitemid 46897261)
54. Davis BN, Hilyard AC, Lagna G and Hata A: SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61, 2008. (Pubitemid 351931982)
55. Ozpolat B, Akar U, Steiner M, et al: Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res 5: 95-108, 2007.
56. Cash AC and Andrews J: Fine scale analysis of gene expression in Drosophila melanogaster gonads reveals programmed cell death 4 promotes the differentiation of female germline stem cells. BMC Dev Biol 12: 4, 2012.
57. Curcio A, Torella D and Indolfi C: Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J 75: 1287-1296, 2011.
58. Liu X, Cheng Y, Chen X, Yang J, Xu L and Zhang C: MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 286: 42371-42380, 2011.
59. An Y, Kang Q, Zhao Y, Hu X and Li N: Lats2 modulates adipocyte proliferation and differentiation via hippo signaling. PloS One 8: e72042, 2013.
60. Wu WH, Hu CP, Chen XP, et al: MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens 24: 1087-1093, 2011.
61. Weir L, Chen D, Pastore C, Isner JM and Walsh K: Expression of gax, a growth arrest homeobox gene, is rapidly downregulated in the rat carotid artery during the proliferative response to balloon injury. J Biol Chem 270: 5457-5461, 1995.
62. Xia S, Tai X, Wang Y, et al: Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells. Am J Respir Cell Mol Biol 44: 66-73, 2011.
63. Saito T, Itoh H, Yamashita J, et al: Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK). Regul Pept 127: 159-167, 2005. (Pubitemid 40185375)
64. Gorski DH, LePage DF, Patel CV, Copeland NG, Jenkins NA and Walsh K: Molecular cloning of a diverged homeobox gene that is rapidly downregulated during the G0/G1 transition in vascular smooth muscle cells. Mol Cell Biol 13: 3722-3733, 1993. (Pubitemid 23157309)
65. Yamashita J, Itoh H, Ogawa Y, et al: Opposite regulation of Gax homeobox expression by angiotensin II and C-type natriuretic peptide. Hypertension 29: 381-387, 1997. (Pubitemid 27074072)
66. Witzenbichler B, Kureishi Y, Luo Z, Le Roux A, Branellec D and Walsh K: Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J Clin Invest 104: 1469-1480, 1999.
67. Wassmann S, Wassmann K, Jung A, et al: Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J Mol Cell Cardiol 43: 301-307, 2007. (Pubitemid 47301935)
68. Sun SG, Zheng B, Han M, et al: miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 12: 56-62, 2011.
69. Zhang Y, Wang Y, Wang X, et al: Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens 29: 1560-1568, 2011.
70. Zheng X, Li A, Zhao L, et al: Key role of microRNA-15a in the KLF4 suppressions of proliferation and angiogenesis in endo thelial and vascular smooth muscle cells. Biochem Biophys Res Commun 437: 625-631, 2013.
71. Cheng Y, Liu X, Yang J, et al: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166, 2009.
72. Quintavalle M, Elia L, Condorelli G and Courtneidge SA: MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 189: 13-22, 2010.
73. Wang YS, Chou WW, Chen KC, Cheng HY, Lin RT and Juo SH: MicroRNA-152 mediates DNMT1-regulated DNA methylation in the estrogen receptor α gene. PloS One 7: e30635, 2012.
74. Li E, Bestor TH and Jaenisch R: Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926, 1992.
75. Huang RS, Hu GQ, Lin B, Lin ZY and Sun CC: MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med 58: 961-967, 2010.
76. Ma X, Ma C and Zheng X: MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role? Heart Lung Circ 22: 811-818, 2013.
77. Remus EW, Lyle AN, Weiss D, et al: miR181a protects against angiotensin II-induced osteopontin expression in vascular smooth muscle cells. Atherosclerosis 228: 168-174, 2013.
78. Wang YS, Wang HY, Liao YC, et al: MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc Res 95: 517-526, 2012.
79. Ammit AJ and Panettieri RA Jr: Invited review: the circle of life: cell cycle regulation in airway smooth muscle. J Appl Physiol (1985) 91: 1431-1437, 2001.
80. Chotani MA, Touhalisky K and Chiu IM: The small GTPases Ras, Rac, and Cdc42 transcriptionally regulate expression of human fibroblast growth factor 1. J Biol Chem 275: 30432-30438, 2000.
81. Lindner V and Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88: 3739-3743, 1991. (Pubitemid 21916699)
82. Hanna AK, Fox JC, Neschis DG, Safford SD, Swain JL and Golden MA: Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury. J Vasc Surg 25: 320-325, 1997. (Pubitemid 27102655)
83. Merlet E, Atassi F, Motiani RK, et al: miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc Res 98: 458-468, 2013.
84. Liu Q, Fu H, Sun F, et al: miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic acids Res 36: 5391-5404, 2008.
85. Sahoo SK, Kim T, Kang GB, Lee JG, Eom SH and Kim do H: Characterization of calumenin-SERCA2 interaction in mouse cardiac sarcoplasmic reticulum. J Biol Chem 284: 31109-31121, 2009.
86. Sun Y, Chen D, Cao L, et al: miR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A. Cardiovasc Res 100: 272-279, 2013.
87. Li P, Liu Y, Yi B, et al: MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res 99: 185-193, 2013.
88. Bonta PI, Pols TW and de Vries CJ: NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc Med 17: 105-111, 2007. (Pubitemid 46518167)
89. Yu ML, Wang JF, Wang GK, et al: Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J 75: 703-709, 2011.
90. Doe Z, Fukumoto Y, Takaki A, et al: Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 73: 1731-1739, 2009.
91. Zhou YC and Waxman DJ: Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b. J Biol Chem 274: 2672-2681, 1999.
92. Chen KC, Hsieh IC, Hsi E, et al: Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J Cell Sci 124: 4115-4124, 2011.
93. Mehta JL, Chen J, Hermonat PL, Romeo F and Novelli G: Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69: 36-45, 2006. (Pubitemid 41814809)
94. Mehta JL and Li DY: Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endo thelial cells. Biochem Biophys Res Commun 248: 511-514, 1998. (Pubitemid 28404451)
95. Tan KS, Armugam A, Sepramaniam S, et al: Expression profile of MicroRNAs in young stroke patients. PloS One 4: e7689, 2009.
96. Urbich C, Kuehbacher A and Dimmeler S: Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588, 2008.
97. Chen KC, Wang YS, Hu CY, et al: OxLDL upregulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 25: 1718-1728, 2011.
98. Aoyagi M, Yamamoto M, Azuma H, et al: Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation. Histochem Cell Biol 109: 97-102, 1998. (Pubitemid 28085681)
99. Gimona M, Kaverina I, Resch GP, Vignal E and Burgstaller G: Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 14: 2482-2491, 2003. (Pubitemid 36724336)
100. Linder S and Aepfelbacher M: Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 13: 376-385, 2003. (Pubitemid 36776715)
101. Kunugi S, Iwabuchi S, Matsuyama D, Okajima T and Kawahara K: Negative-feedback regulation of ATP release: ATP release from cardiomyocytes is strictly regulated during ischemia. Biochem Biophys Res Commun 416: 409-415, 2011.
102. Bennett MR: Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 41: 361-368, 1999.
103. Fuster V: Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90: 2126-2146, 1994.
104. Davies MJ, Richardson PD, Woolf N, Katz DR and Mann J: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377-381, 1993. (Pubitemid 23171108)
105. Geng YJ and Libby P: Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 147: 251-266, 1995.
106. Sedding DG, Widmer-Teske R, Mueller A, et al: Role of the phosphatase PTEN in early vascular remodeling. PloS One 8: e55445, 2013.
107. Geng YJ: Molecular signal transduction in vascular cell apoptosis. Cell Res 11: 253-264, 2001.
108. Clowes AW, Clowes MM, Fingerle J and Reidy MA: Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 14 (Suppl 6): S12-S15, 1989. (Pubitemid 19267924)
109. Li W, Liu G, Chou IN and Kagan HM: Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J Cell Biochem 78: 550-557, 2000. (Pubitemid 30620701)
110. Lazarus HM, Cruikshank WW, Narasimhan N, Kagan HM and Center DM: Induction of human monocyte motility by lysyl oxidase. Matrix Biol 14: 727-731, 1995. (Pubitemid 26014659)
111. Kothapalli D, Liu SL, Bae YH, et al: Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening. Cell Rep 2: 1259-1271, 2012.
112. Iyemere VP, Proudfoot D, Weissberg PL and Shanahan CM: Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260: 192-210, 2006. (Pubitemid 44253633)
113. Du Y, Gao C, Liu Z, et al: Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol 32: 2580-2588, 2012.
114. Wang L, Zheng J, Bai X, et al: ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 104: 688-698, 2009.
115. Liu CJ, Kong W, Ilalov K, et al: ADAMTS-7: a metallopro teinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J 20: 988-990, 2006.
116. Du Y, Wang Y, Wang L, et al: Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ Res 108: 917-928, 2011.
117. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L and Natarajan R: Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 59: 2904-2915, 2010.
118. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR and Hofbauer LC: miR-125b regulates calcification of vascular smooth muscle cells. Ame J Pathol 179: 1594-1600, 2011.
119. Zhu F, Friedman MS, Luo W, Woolf P and Hankenson KD: The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation. J Cell Physiol 227: 2677-2685, 2012.